4//SEC Filing
Farley Brian E 4
Accession 0001209191-18-041640
CIK 0001227636other
Filed
Jul 4, 8:00 PM ET
Accepted
Jul 5, 4:32 PM ET
Size
20.8 KB
Accession
0001209191-18-041640
Insider Transaction Report
Form 4
Farley Brian E
Director
Transactions
- Conversion
Common Stock
2018-07-02+8,483→ 84,065 total - Conversion
Common Stock
2018-07-02+15,342→ 99,407 total - Conversion
Common Stock
2018-07-02+1,506→ 110,438 total - Conversion
Series D Covertible Preferred Stock
2018-07-02−8,483→ 0 total→ Common Stock (8,483 underlying) - Conversion
Series E Covertible Preferred Stock
2018-07-02−15,342→ 0 total→ Common Stock (15,342 underlying) - Conversion
Series F Covertible Preferred Stock
2018-07-02−9,525→ 0 total→ Common Stock (9,525 underlying) - Conversion
Series G Covertible Preferred Stock
2018-07-02−1,506→ 0 total→ Common Stock (1,506 underlying) - Conversion
Common Stock
2018-07-02+9,525→ 108,932 total - Award
Stock Option Grant (Right to Buy)
2018-07-02+10,959→ 10,959 totalExercise: $5.22Exp: 2028-04-25→ Common Stock (10,959 underlying)
Footnotes (2)
- [F1]Each share of Series D Convertible Preferred Stock, Series E Convertible Preferred Stock, Series F Convertible Preferred Stock and Series G Convertible Preferred Stock was convertible at any time, at the option of the holder, into Common Stock, on a one-for-one basis, had no expiration date and converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering.
- [F2]The performance criterion for vesting of this option was met upon the closing of the Issuer's initial public offering. One twelfth (1/12th) of the shares subject to the option vested or shall vest monthly commencing on March 16, 2018, subject to Reporting Person continuing to provide service through each such date.
Documents
Issuer
Neuronetics, Inc.
CIK 0001227636
Entity typeother
Related Parties
1- filerCIK 0001306117
Filing Metadata
- Form type
- 4
- Filed
- Jul 4, 8:00 PM ET
- Accepted
- Jul 5, 4:32 PM ET
- Size
- 20.8 KB